Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- DR Congo: New initiative to eliminate HIV in children ‘a beacon of hope’, says UN
- WHO study shows tobacco control efforts protect three-quarters of the world’s population
- Drinking coffee can help you live longer, a new study reveals
- New study finds women who work night shifts are more likely to have asthma
- New UN report shows social, economic barriers are factors leading to global fertility crisis
